Most popular

What is the use of Cytotron?

What is the use of Cytotron?

Cytotron is intended to cause degeneration of uncontrolled growth of tissues. “It is indicated for treating protein-linked, abnormally regenerating disorders such as neoplastic disease, and allowing extended progression free survival, with pain relief, palliation, improved quality and dignity of life,” says the letter.

Who invented the Cytotron?

The CYTOTRON is a novel, patented therapeutic device, invented by Dr. Rajah Vijay Kumar and his team at Centre for Advanced Research and Development (CARD), the R&D wing of Scalene Cybernetics Limited, an Indian Technology company.

What is Rfqmr?

Generically known as Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR), it is a technology that is made to deliver highly complex quantum instantaneous Nuclear Magnetic Resonance beams in the RF bands and its harmonics ranging from 3KHz to 300 MHz with a near field delivery using specialized antenna in the …

Is Cytotron FDA approved?

The FDA recognizes the Cytotron as a Breakthrough Device for the treatment of Breast, Pancreas and Liver Cancers, by conducting a clinical trial to establish that it is better than existing standards of care for these indications.

Is Cytotron available in India?

In India, this machine is not yet available, although they claim to give treatment to people at their centre. “In India, the Cytotron will cost anywhere between Rs 2.5 to Rs 3 crore,” says Dr Kumar.

What is Rotational Field Quantum Magnetic Resonance?

Rotational Field Quantum Magnetic Resonance (RFQMR) is a technology that is made to deliver highly complex quantum electromagnetic beams in the sub-radio and near-radio frequency spectrum.

Is Erleada a biologic?

Apalutamide is an antiandrogen, and acts as an antagonist of the androgen receptor, the biological target of androgens like testosterone and dihydrotestosterone….Apalutamide.

Clinical data
License data US DailyMed: Erleada
Pregnancy category AU : D
Routes of administration By mouth
Drug class Nonsteroidal antiandrogen

Is prostate MD FDA approved?

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

What is Cytotron device?

The Cytotron® is a stand-alone device based on Rotational Field Quantum Magnetic Resonance (RFQMR) platform technology which enables whole body therapeutics called Quantum Magnetic Resonance Therapy (QMRT).

Is apalutamide FDA approved?

On September 17, 2019, the Food and Drug Administration approved apalutamide (ERLEADA, Janssen Biotech, Inc) for patients with metastatic castration-sensitive prostate cancer (mCSPC). Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate cancer.

Is Erleada a chemo drug?

Erleada (apalutamide) Chemotherapy, Side Effects – Navigating Care.

Is Orgovyx better than Lupron?

In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at reducing testosterone levels in men with advanced prostate cancer than another commonly used treatment, leuprolide (Lupron).